SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : dsco Discovery Laboratories -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (228)4/20/2009 10:21:39 AM
From: Arthur Radley  Read Replies (1) | Respond to of 318
 
Ken and RK,
Following this company and management missteps has been frustrating! The promise of this delivery system has always been intriguing as to the host of applications. With this delay today, I just don't see how they will be able to remain independent....one could hope that J&J would come back into the picture.

I spent some time this weekend looking at various stocks for some rebalancing that I need to do.......after pouring over Barron's to get some basic data and then more indepth research I came up with a short list. One of them was (JAVA)....now if I had only done this Friday....with news out today! (:<) Appears I'm a day late!

Just by chance...do either of you follow AMLN?



To: kenhott who wrote (228)4/20/2009 11:58:14 AM
From: kenhott1 Recommendation  Respond to of 318
 
I double checked and Kingbridge's latest Dec08 funding deal w/DSCO is at a min. price of $.60/shr. I thought it was like $1 (The May08 deal $1.15/shr min). Good memory as always. DECO can still draw up to like 15m shares with the Dec08 deal as long as the price stays over $.60. Maybe Kingbridge is out there shorting today. Sell high, buy low.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News